MeDiC researchers

Researchers with the Metabolic Disorders and Complications Program (MeDiC)

The Metabolic Disorders and Complications Program (MeDiC) brings together a team of outstanding research scientists who share the goal of developing new diagnostic tools, treatments and health policies for obesity, diabetes and osteoporosis, along with their complications, including kidney failure, heart disease, fatty liver/cirrhosis, dementia and stroke.

More than one in three Canadians are affected by common and chronic metabolic disorders. The MeDiC Program unites multidisciplinary researchers to study these problems in both adults and children. Each member of the MeDiC program is also affiliated with at least one of the research centres at the Research Institute of the McGill University Health Centre: the Centre for Translational Biology, the Centre for Innovative Medicine and the Centre for Outcomes Research and Evaluation.

To learn more about the MeDiC program, visit our Events, News and Contact Us pages.
 

Centre for Translational Biology (CTB)
Centre for Innovative Medicine (CIM)
Centre for Outcomes Research and Evaluation (CORE)
McGill University-based Researchers
Associate investigators of the MeDiC Program

Subheading - Centre for Translational Biology (CTB)

Centre for Translational Biology (CTB)

Asset Publisher

Andrew Bateman, PhD

Progranulin

neuroprotection

tissue repair

growth factors

cell communication

Barry Bedell, MD, PhD

Imaging

MRI

PET

image processing

neuropathology

Hugh Bennett, PhD

progranulin

zebrafish

motor neuron development

protein structure and function

high-performance liquid chromatography (HPLC)

Stéphanie Chevalier, PhD

nutrition

metabolism

insulin resistance

stable isotopes

clinical and translational research

Martine Culty

testis

spermatogenesis

stem cells

differentiation

signaling pathways

Andrey Cybulsky, MD

cell injury

glomerulonephritis

phospholipases

protein kinases

stress proteins

George Fantus, MD, FRCPC

Insulin resistance

tyrosine kinase and phosphatase

glucose metabolism

diabetes complications

oxidative stress

David Goltzman, MD

calcium and mineral metabolism

hormonal regulation

bone metabolism

osteoporosis

parathyroid disorders

Ahmad Haidar, PhD

Type 1 diabetes

clinical research

artificial pancreas systems

automated insulin delivery system

randomized controlled trials

Stéphane Laporte, PhD

G protein-coupled receptor

molecular pharmacology

cell imaging

cardiovascular diseases

pre-term birth.

Louise Larose, PhD

intracellular signaling

adaptor proteins

unfolded protein response

insulin resistance

obesity and diabetes

Serge Lemay, MD

tyrosine kinase

adaptor proteins

acute kidney injury

cell signaling

Jun-Li Liu, PhD

growth and development

transgenic mice

Cre/loxP system

insulin-like growth factor

Reg family proteins

Errol Marliss, MD, FRCPC

Nutrition

metabolism

diabetes

obesity

insulin resistance

Vassilios Papadopoulos, PhD

steroids

neurosteroids

pharmacology

drug discovery

endocrinology

Steven Paraskevas, MD, PhD

islets of Langerhans

type 1 diabetes

cell death

inflammation

ischemia-reperfusion injury

Shafaat Rabbani, MD

Breast and prostate cancer

DNA methylation

proteases and growth factors

bone metastasis

cancer progression

Christian Rocheleau, PhD

epidermal growth factor receptor (EGFR)

Ras protein

Caenorhabditis elegans

Rab proteins

vesicular trafficking

Tomoko Takano, MD, PhD

nephrotic syndrome

proteinuria

podocytes

Rho-GTPases

cytoskeleton

Elena Torban, PhD

kidney development

planar cell polarity

cilia formation and ciliophaties

glomerular disease

mouse models of human kidney diseases

Jeremy Van Raamsdonk, PhD, M.Sc

aging

neurodegeneration

Parkinson's disease

Huntington's disease

mitochondria

Simon Wing, MD

ubiquitin

muscle wasting

spermatogenesis

cachexia

diabetes

Subheading - Centre for Innovative Medicine (CIM)

Centre for Innovative Medicine (CIM)

Asset Publisher

Sero Andonian, MD

Endourology

kidney stone disease

radiation safety

medical education

minimally invasive surgery

Paul Barré, MD, FRCPC, CSPQ

chronic kidney disease

hemodialysis

metabolic bone disease

polycystic kidney disease

anemia

Ralph Lattermann, MD, PhD

glucose metabolism

protein catabolism

surgery

anesthesia

liver function

José Morais, MD

protein

muscle

muscle protein

Thomas Schricker, MD, PhD

catabolic response to surgery

clinical outcomes

perioperative nutrition

Jean-François Yale, MD, FRCPC

clinical trials in diabetes

hypoglycemia

intensive management of diabetes

adherence

Subheading - Centre for Outcomes Research and Evaluation (CORE)

Centre for Outcomes Research and Evaluation (CORE)

Asset Publisher

David Buckeridge, MD, PhD

biosurveillance

public health

medical informatics

Deborah Da Costa, PhD

Mental health

behavioural medicine

e-health

pregnancy/postpartum

chronic illnesses

Kaberi Dasgupta, MD, M.Sc.

diabetes

physical activity

hypertension

eating patterns

vascular risk

Steven Grover, MD

clinical epidemiology

clinical guidelines

computer modelling

cost effectiveness

health promotion

Suzanne Morin, MD, M.Sc., FRCP, FACP

Osteoporosis

fractures

bone mineral density

administrative healthcare databases

atypical femur fractures

Elham Rahme, PhD

pharmacoepidemiology

drug utilisation

drug adverse events

tumour necrosis factor inhibitors

anticoagulants

Ruth Sapir-Pichhadze, BMedSc, MD, MSc, PhD, FRCPC

kidney transplantation

nephrology

clinical epidemiology

clinical research

histocompatibility

Subheading - McGill University-based Researchers

McGill University-based Researchers

Asset Publisher

Robert Sladek, MD

genetics

type 2 diabetes

obesity